Results 151 to 160 of about 4,153 (212)

Efficacy and Safety of Finerenone in Kidney Transplant Patients. [PDF]

J Clin Med
Kahvecioglu S, Celik H, Yalcinkaya AS, Ayar Y, Aktas N, Akarsu O.   +5 more
europepmc   +1 more source

Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. [PDF]

J Clin Med
Tinti MD, De Gennaro L, Limonta R, De Maria R, Carigi S, Bianco M, Di Nora C, Manca P, Matassini MV, Rizzello V, D'Elia E, Benvenuto M, Cittar M, Halasz G, Iacoviello M, Gabrielli D, Colivicchi F, Bilato C, Nardi F, Grimaldi M, Oliva F.   +20 more
europepmc   +1 more source

Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations. [PDF]

BMC Nephrol
Raza SA, Rehman AU, Aamir AH, Qureshi F, Sajid A, Waseem T, Abbasi MSR, Farooq F, Sachdewani R, Raja UY, Akram J, Syed U, Iqtadar S, Nabi Z, Mand A, Mal P, Shah ST, Mohsin A, Mohydin B, Sheikh A, Rizwan A, Mushtaq M.   +21 more
europepmc   +1 more source

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease. [PDF]

J Clin Med
Nakhleh A, Khazim K, Shehadeh N.
europepmc   +1 more source

Management of chronic kidney disease in a 65-year-old man with diabetes. [PDF]

CMAJ
Dubrofsky L, Cherney DZI, Odutayo A.
europepmc   +1 more source

Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Chen YH, Fang YW, Chen MT, Liou HH, Tsai MH.   +4 more
europepmc   +1 more source

Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights From a Real-World Cohort. [PDF]

Struct Heart
Massad F, Badwan O, Rosenzveig A, Zghyer F, Shahrori Z, Motairek I, Hatab T, Alkhatib R, Kapadia S.   +8 more
europepmc   +1 more source

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. [PDF]

Diabetes Care
Ostrominski JW, Lu H, Claggett BL, Desai AS, Jhund PS, Henderson AD, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Brinker M, Schloemer P, Rohwedder K, McMurray JJV, Solomon SD, Vaduganathan M.   +17 more
europepmc   +1 more source

The mineralocorticoid receptor antagonist finerenone enhances cardiovascular recovery upon food intake normalization in obese mice. [PDF]

Cardiovasc Diabetol
Manon MF, Marie PD, Benjamin B, Coralie F, Linghui K, Amhrae ND, Lionel N, Saïda M, Sylvanie R, Anaïs D, Vincent R, Bruno F, Frédéric J, Sheerazed B, Paul M, Antoine OP.   +15 more
europepmc   +1 more source